Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cui, Jiuwei  [Clear All Filters]
2024
Wang W, Zhou L, Li H, Sun T, Wen X, Li W, Esteban MA, Hoffman AR, Hu J-F, Cui J. Profiling the role of m6A effectors in the regulation of pluripotent reprogramming. Hum Genomics. 2024;18(1):33.
2023
Li X, Chen N, Zhou L, Wang C, Wen X, Jia L, Cui J, Hoffman AR, Hu J-F, Li W. Erratum: Genome-wide target interactome profiling reveals a novel epigenetic pathway for oncogenic lncRNA in breast cancer. Am J Cancer Res. 2023;13(9):4490-4491.
Liu MM, Ji W, Zhao X, Liu X, Hu J-F, Cui J. Therapeutic potential of engineering the mitochondrial genome. Biochim Biophys Acta Mol Basis Dis. 2023:166804.
2020
Zhan X, Guo S, Li Y, Ran H, Huang H, Mi L, Wu J, Wang X, Xiao D, Chen L, et al. Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation. J Exp Med. 2020;217(5).
2018
Du Z, Jia L, Wang Y, Wang C, Wen X, Chen J, Zhu Y, Yu D, Zhou L, Chen N, et al. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. Sci Data. 2018;5:180255.
Sun L, Feng L, Cui J. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol. 2018;13(1):72.
2016
Zhang Y, Hu J-F, Wang H, Cui J, Gao S, Hoffman AR, Li W. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget. 2016.
2015
Zhu X, Pan X, Yao L, Li W, Cui J, Wang G, Mrsny RJ, Hoffman AR, Hu J-F. Converting Skin Fibroblasts Into Hepatic-Like Cells by Transient Programming. J Cell Biochem. 2015.